mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.2 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.061 |
0.2 |